Lunai Bioworks Inc (LNAI)

Dec 04, 2025

Lunai Bioworks (LNAI) Stock Analysis Report | Financials & Insights - Benzinga

Dec 04, 2025

Dec 03, 2025

Lunai Bioworks enters sales agreement with Dawson James SecuritiesSEC filing - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Lunai Bioworks Enters Sales Agreement with Dawson James - TipRanks

Dec 03, 2025

Dec 01, 2025

Does Lunai Bioworks Inc (LNAI) offer a good opportunity for investors? - Setenews

Dec 01, 2025

Nov 29, 2025

Lunai Bioworks’ immune cell therapy shows tumor regression, wins first license - MSN

Nov 29, 2025

Nov 28, 2025

Lunai Bioworks stock soars after securing first licensing deal for cancer therapy - MSN

Nov 28, 2025

Nov 28, 2025

Lunai Bioworks - The Pharma Letter

Nov 28, 2025

Nov 27, 2025

Lunai Bioworks lands first licensing deal for off-the-shelf cancer immunotherapy - The Pharma Letter

Nov 27, 2025

Nov 26, 2025

There is no way Lunai Bioworks Inc (LNAI) can keep these numbers up - Setenews

Nov 26, 2025

Nov 25, 2025

Lunai Bioworks Inc (2Q50.MU) latest stock news and headlines - Yahoo Finance Australia

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks Inc. (LNAI) -7.5% in After-hours: Shares Decline Amidst New Licensing Agreement - Stocks Telegraph

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks Secures $3.1M in Private Placement - TipRanks

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks sells 3,133,333 shares in private financing deal - Stock Titan

Nov 25, 2025

Nov 25, 2025

LNAI Stock: Surging or Slipping? - StocksToTrade

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks (LNAI) Stock: Plummets 14.2% Despite Breakthrough in Cancer Immunotherapy - parameter.io

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks Shares Rise After Company Secures Licensing Intent for Dendritic Cell Therapy - marketscreener.com

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks: Stock Surge or Bubble? - timothysykes.com

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks stock soars after securing first licensing deal for cancer therapy By Investing.com - Investing.com South Africa

Nov 25, 2025

Nov 25, 2025

LNAI's Groundbreaking Immune Cell Therapy Advances with Key Lice - GuruFocus

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks Secures First Licensing LOI Following Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models - MarketScreener

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models - Yahoo Finance

Nov 25, 2025

Nov 25, 2025

Lunai Bioworks rises on early licensing interest in DCCT therapy | Tap to know more | Inshorts - Inshorts

Nov 25, 2025

Nov 24, 2025

Lunai Bioworks Inc. (LNAI) -7.5% in After-hours: Routine Trading Amid Price Decline - Stocks Telegraph

Nov 24, 2025

Nov 23, 2025

Lunai Bioworks Inc (2Q50.MU) options chain - Yahoo Finance Australia

Nov 23, 2025

Nov 23, 2025

Lunai Bioworks Inc. (LNAI) -13.9% in Normal Trading: Price Declines Amid Routine Trading - Stocks Telegraph

Nov 23, 2025

Nov 23, 2025

What is the current Price Target and Forecast for Lunai Bioworks Inc. (LNAI) - Zacks Investment Research

Nov 23, 2025

Nov 23, 2025

Lunai Bioworks Inc. announced that it expects to receive $3.133333 million in funding - marketscreener.com

Nov 23, 2025

Nov 21, 2025

Lunai Bioworks Inc Com (LNAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025

Nov 21, 2025

Lunai Bioworks Inc (2Q50.MU) analyst ratings, estimates and forecasts - Yahoo Finance Australia

Nov 21, 2025

Nov 19, 2025

Lunai Bioworks Inc (2Q50.MU) Valuation Measures & Financial Statistics - Yahoo! Finance Canada

Nov 19, 2025

Nov 17, 2025

Are Smart Investors Making the Right Decision? Lunai Bioworks Inc (LNAI) - Setenews

Nov 17, 2025

Nov 17, 2025

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Greenville Online

Nov 17, 2025

Nov 15, 2025

Lunai Bioworks Inc. (LNAI) stock price, news, quote and history - Yahoo Finance Australia

Nov 15, 2025

Nov 15, 2025

Lunai Bioworks: Fiscal Q1 Earnings Snapshot - New Haven Register

Nov 15, 2025

Nov 14, 2025

Lunai Bioworks Inc. Reports Earnings Results for the First Quarter Ended September 30, 2025 - MarketScreener

Nov 14, 2025

Nov 14, 2025

[10-Q] Lunai Bioworks Inc. Quarterly Earnings Report | RENB SEC FilingForm 10-Q - Stock Titan

Nov 14, 2025

Nov 10, 2025

A better buy-in window may exist right now for Lunai Bioworks Inc (LNAI) - Setenews

Nov 10, 2025

Nov 09, 2025

A Mandatory Rebranding: Lunai Bioworks Emerges from Enochian’s Ashes - Ad-hoc-news.de

Nov 09, 2025

Nov 09, 2025

Lunai Bioworks Inc. (2Q50.F) Company Profile & Facts - Yahoo! Finance Canada

Nov 09, 2025

Nov 09, 2025

Lunai Bioworks Inc. (LNAI) Stock Major Holders - Yahoo! Finance Canada

Nov 09, 2025

Nov 09, 2025

Top Biotech Stocks To Follow NowNovember 5th - MarketBeat

Nov 09, 2025

Nov 07, 2025

Lunai Bioworks Inc. (LNAI) Stock Forecast & Price Prediction 2025–2030 - CoinCodex

Nov 07, 2025

Nov 07, 2025

Lunai Bioworks Inc. (LNAI) latest press releases and corporate news - Yahoo Finance UK

Nov 07, 2025

Nov 07, 2025

Top Biotech Stocks To Follow Now – November 5th - Defense World

Nov 07, 2025

Nov 07, 2025

Lunai Bioworks Inc (2Q50.MU) Latest Press Releases & Corporate News - Yahoo! Finance Canada

Nov 07, 2025

Nov 06, 2025

[8-K] Lunai Bioworks Inc. Reports Material Event | RENB SEC FilingForm 8-K - Stock Titan

Nov 06, 2025

Nov 06, 2025

Lunai Bioworks Inc. (LNAI) stock historical prices and data - Yahoo Finance UK

Nov 06, 2025

Nov 06, 2025

Lunai Bioworks Inc. (LNAI) interactive stock chart - Yahoo Finance UK

Nov 06, 2025

Nov 06, 2025

Lunai Bioworks Inc. (LNAI) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 06, 2025

Nov 06, 2025

This trade activity should not be overlooked: Lunai Bioworks Inc (LNAI) - Setenews

Nov 06, 2025

Nov 06, 2025

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthro - ANP Persportaal

Nov 06, 2025

Nov 06, 2025

Lunai Bioworks achieves complete regression… - digitalmore.co

Nov 06, 2025

Nov 06, 2025

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy - The Manila Times

Nov 06, 2025

Nov 05, 2025

Lunai Bioworks (NASDAQ: LNAI) Stock Soars 40% on Breakthrough AI-Powered Pancreatic Cancer Therapy Results - parameter.io

Nov 05, 2025